SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma reports Profit after tax of Rs 505.60 Mln, in the June 2021 quarter

04 Aug 2021 Evaluate
A fair growth of 16.40% in the revenue at Rs. 4055.70 millions was reported in the June 2021 quarter as compared to Rs. 3484.20 millions during year-ago period.Modest increase of 20.12% in the Net Profit was reported from. 420.90 millions to Rs. 505.60  millions.OP of the company witnessed a marginal growth to 976.60 millions from 880.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 4055.70 3484.20 16.40 4055.70 3484.20 16.40 16168.80 13217.50 22.33
Other Income 58.00 45.80 26.64 58.00 45.80 26.64 284.10 275.10 3.27
PBIDT 976.60 880.60 10.90 976.60 880.60 10.90 4137.40 2840.40 45.66
Interest 189.20 198.30 -4.59 189.20 198.30 -4.59 844.70 778.80 8.46
PBDT 781.60 682.30 14.55 781.60 682.30 14.55 3292.70 2061.60 59.72
Depreciation 276.00 261.40 5.59 276.00 261.40 5.59 1083.10 936.70 15.63
PBT 505.60 420.90 20.12 505.60 420.90 20.12 2209.60 1124.90 96.43
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -88.40 -74.20 19.14 -88.40 -74.20 19.14 -386.40 -206.90 86.76
PAT 505.60 420.90 20.12 505.60 420.90 20.12 2209.60 1124.90 96.43
Equity 359.20 268.55 33.76 359.20 268.55 33.76 359.20 268.50 33.78
PBIDTM(%) 24.08 25.27 -4.73 24.08 25.27 -4.73 25.59 21.49 19.07

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×